EONE continues its efforts to serve as a leader
of the medical science of the future
| Test Code | Test item | Specimen | Test Schedule | analytic time |
|---|---|---|---|---|
| H0515 | ATP7A gene, mutation | WB(EDTA) | Mon-Thu | 20 days |
| A6085 | ATP7B gene, mutation (full sequencing) | WB(EDTA) | Mon-Thu | 23 days |
| H0577 | ATP8B1 gene mutation (PFIC1) | WB(EDTA) | Mon-Thu | 5 weeks |
| A0370 | Au (Gold) | Serum | Tue,Fri | 15 days |
| A0370 | Au (Gold) | Urine | Tue,Fri | 15 days |
| C6821 | Auto hemolysis test | WB(Heparin) | Mon,Tue | 5 days |
| H0621 | Autoimmune Target Test (AIT) Qualitative | Serum | Tue,Fri | 7 days |
| H06211 | Autoimmune Target Test (AIT) Quantitative | Serum | Tue,Fri | 7 days |
| A6590 | AVPR2 gene mutation | WB(EDTA) | Mon-Thu | 4 weeks |
| B47722 | B cell (CD19) | WB(EDTA) | Mon-Sat | 1 day |
| B47799 | B cell (CD19) | Bronchial Aspirate | Mon-Sat | 1 day |
| C6058 | B cell Panel | Bone marrow | Mon-Thu | 2 weeks |
| C6058 | B cell Panel | Cell pellet | Mon-Thu | 2 weeks |
| C6058 | B cell Panel | other | Mon-Thu | 2 weeks |
| H0940 | B Lymphoma / CLL follow-up panel (5) [Bone marrow] | Bone marrow | Mon-Thu | 6 days |
| H0939 | B Lymphoma / CLL follow-up panel (5) [Whole blood] | WB(EDTA) | Mon-Thu | 6 days |
| H0938 | B Lymphoma / CLL screening panel (12) [Bone marrow] | Bone marrow | Mon-Thu | 6 days |
| H0937 | B Lymphoma / CLL screening panel (12) [Whole blood] | WB(EDTA) | Mon-Thu | 6 days |
| H0870 | B-ALL MRD (Flow Cytometry) | Bone marrow | Mon-Thu | 10 days |
| H0870 | B-ALL MRD (Flow Cytometry) | WB(EDTA) | Mon-Thu | 10 days |